Atrioventricular Block After EVOQUE Transcatheter Tricuspid Valve Replacement

•Based on a real-world study of 106 Evoque transcatheter tricuspid valve replacement (TTVR) recipients, a total of 14 (25%) cases of new atrioventricular (AV) block occurred after Evoque implantation in the 55 patients without prior pacemakers who met study inclusion criteria. This incidence is similar to that reported in the TRISCEND II clinical trial.•New AV block occurred in a median of 26 hours after Evoque TTVR (interquartile range: 5-60 hours), but there were cases of new AV block that occurred as late as 7 days after the procedure.•Of the 14 new cases of AV block, 12 were treated successfully with implantation of a leadless pacemaker (Micra) under fluoroscopic guidance without procedural complications or compromising the valve implantation.•The institutional strategy of 48-hour post-Evoque inpatient monitoring for all patients followed by mobile cardiac outpatient telemetry identified 11 of 14 cases of new AV block as before discharge from the hospital and 1 case as an outpatient before symptom onset.

Authors

Institutions

Publication Details

Journal
Structural Heart
Published
2025-07-16
DOI
https://doi.org/10.1016/j.shj.2025.100701
Citations
2
Primary Topic
Cardiac pacing and defibrillation studies
Type
article
Field-Weighted Citation Impact
2.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Atrioventricular Block After EVOQUE Transcatheter Tricuspid Valve Replacement

Mohamad Raad, Brian Vickers, Georgi Fram, Hussayn Alrayes et al.
2 citations
Structural Heart
Cardiac pacing and defibrillation studies
2.78
article

Atrioventricular Block After EVOQUE Transcatheter Tricuspid Valve Replacement

Mohamad Raad, Brian Vickers, Georgi Fram, Hussayn Alrayes, Marc K. Lahiri, Pedro Engel Gonzalez, Bryan Zweig, Brian Patrick O’Neill, Waddah Maskoun, John Dawdy, Felix Nguyen, Karl Ilg, Omar Abdelhai, J.W. Greenberg, Tiberio Frisoli, Janet Wyman, Brian La Starza, Gautam Rangavajla, Leo Kar Lok Lai, Ritik Patel, Sachin Parikh, James Lee, William W. O’Neill, Pedro Villablanca, Matthew Ebinger, Arfaat Khan, N. Bowerman
article en
2 citations

Abstract

•Based on a real-world study of 106 Evoque transcatheter tricuspid valve replacement (TTVR) recipients, a total of 14 (25%) cases of new atrioventricular (AV) block occurred after Evoque implantation in the 55 patients without prior pacemakers who met study inclusion criteria. This incidence is similar to that reported in the TRISCEND II clinical trial.•New AV block occurred in a median of 26 hours after Evoque TTVR (interquartile range: 5-60 hours), but there were cases of new AV block that occurred as late as 7 days after the procedure.•Of the 14 new cases of AV block, 12 were treated successfully with implantation of a leadless pacemaker (Micra) under fluoroscopic guidance without procedural complications or compromising the valve implantation.•The institutional strategy of 48-hour post-Evoque inpatient monitoring for all patients followed by mobile cardiac outpatient telemetry identified 11 of 14 cases of new AV block as before discharge from the hospital and 1 case as an outpatient before symptom onset.

Structural HeartVol. 9(9)
Wayne State University (US), Henry Ford Hospital (US)
Openalex Percentile: Top 9%
Cardiac pacing and defibrillation studies
2.78
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.